A prospective, multicenter, open-label, clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for treatment of unresectable hepatocellular carcinoma (HCC): DOORwaY90. (2021) - Mahvash, A.; Chartier, S.; Turco, M.; Habib, P.; Griffith, S.; Brown, S.; Kappadath, S.C.